- Lichen International Limited reported a **net loss of ($9.182 million)** for the six months ended June 30, 2025, compared to a net income of $0.767 million for the same period in 2024.  **[1876766_0001185185-25-001237_licnex99-1.htm:1]**  Total revenues for the six months ended June 30, 2025, were **$14.26 million**, marking a **21.2% decrease** from $18.10 million in the prior year period.  **[1876766_0001185185-25-001237_licnex99-1.htm:1]** 
- The company is undergoing a **strategic shift** from 2025, gradually transitioning towards **IPO advisory services and external equity investments**, while winding down its education support services.  **[1876766_0001185185-25-001237_licnex99-1.htm:1]** **[1876766_0001185185-25-001237_licnex99-1.htm:2]** 
- Key corporate actions include changing its name to **Lichen International Limited** on **February 10, 2025**, implementing a **one-for-two-hundred (1:200) reverse stock split** on **March 3, 2025**, and completing the acquisition of the remaining **40% equity interest in Bondly HK** for **US$5,330,000** on **February 26, 2025**.  **[1876766_0001185185-25-001237_licnex99-1.htm:0]** **[1876766_0001185185-25-001237_licnex99-2.htm:21]** 
- On **September 19, 2025**, the company closed a private placement, selling up to **15,500,000 Class A ordinary shares** at **$1.20 per share**, which generated approximately **$18,600,000** in gross proceeds.  **[1876766_0001185185-25-001237_licnex99-1.htm:0]** **[1876766_0001185185-25-001237_licnex99-2.htm:26]**

Lichen International Limited Reports Q2 2025 Results, Announces Strategic Shift and Recent Corporate Actions

- Lichen International Limited entered into securities purchase agreements on **September 15, 2025**, for the issuance and sale of **15,500,000 Class A ordinary shares**.  **[1876766_0001185185-25-001236_licn6k091725.htm:0]** 
- The shares were sold at a price of **$1.20 per share**, resulting in a total purchase price of **$18,600,000**, which was paid in cash.  **[1876766_0001185185-25-001236_licn6k091725.htm:0]** **[1876766_0001185185-25-001236_lichenex10-1.htm:0]** 
- The company received the purchase price and issued the shares on **September 19, 2025**, through a private placement exempt from registration requirements.  **[1876766_0001185185-25-001236_licn6k091725.htm:0]**

Lichen International (LICN)